Product Description
Mechanisms of Action: INST Inhibitor
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Vaginal
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Hillier, Sharon, PhD
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Other|HIV Infections